Plus Therapeutics subsidiary CNSide Diagnostics has reported data from the multi-centre FORESEE trial, which highlights the ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

Using cerebrospinal fluid, researchers have identified proteins and genes linked to Alzheimer's progression that could form ...

A research group at LMU University Hospital has investigated how Alzheimer’s disease can be diagnosed more reliably in the future.

CNSide identified extensive, actionable mutational changes, and clinically relevant longitudinal biomarkers ...